Octyl triazone
This article was originally published in The Rose Sheet
Executive Summary
Hawaiian Tropic Tanning Research Laboratories is "fully supportive" of BASF's Time and Extent Application for Uvinul T-150 (octyl triazone), company says in Jan. 7 comments to FDA. While Hawaiian Tropic has not worked with the sunscreen, literature indicates it is a strong UVB absorber with additional advantage of being photostable, firm states. "The list of sunscreens available for use in the U.S. is relatively small when compared to those available in Europe," Hawaiian Tropic says. "To develop the best possible products for the U.S. consumer, sunscreen manufacturers need as many sunscreen choices as possible." Johnson & Johnson earlier submitted comments supporting the TEA. BASF first petitioned FDA to designate octyl triazone a Category I sunscreen ingredient in 1996 (1"The Rose Sheet" Dec. 2, 1996, p. 8)...
You may also be interested in...
Octyl triazone inclusion in sunscreen TFM based on foreign use data sought by BASF.
OCTYL TRIAZONE INCLUSION IN SUNSCREEN MONOGRAPH SOUGHT BY BASF AG as a Category I (generally recognized as safe and effective) sunscreen ingredient on the basis of its foreign marketing experience. In a Nov. 15 petition filed by the Washington, D.C. office of Morgan, Lewis & Bockius, Germany-based BASF asks FDA to reopen the administrative record of the OTC Sunscreen Drug Products review to include octyl triazone, which the company sells overseas under the trade name Uvinul T 150. The ingredient was approved in the European Union in 1989 and in Japan in March.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.